Jessica Xiaolin Shen Net Worth

What's Jessica Shen's mailing address?

Jessica's mailing address filed with the SEC is C/O POLARITYTE, INC., 1960 S. 4250 WEST, SALT LAKE, UT, 84104.

Insiders trading at PolarityTE Inc

Over the last 6 years, insiders at PolarityTE Inc have traded over $998,958 worth of PolarityTE Inc stock and bought 381,180 units worth $1,230,731 . The most active insiders traders include Steve Gorlin, Peter A Cohen a Paul Elliot Mann. On average, PolarityTE Inc executives and independent directors trade stock every 21 days with the average trade being worth of $3,753. The most recent stock trade was executed by Chris Nolet on 12 January 2023, trading 36,497 units of PTE stock currently worth $8,759.

What does PolarityTE Inc do?

polarityte, inc. (nasdaq: cool) is the owner of a novel regenerative medicine and tissue engineering platform developed and patented by denver lough md, phd. this radical and proprietary technology employs a patients'​ own cells for the healing of full-thickness functionally-polarized tissues. if clinically successful, the polarityte platform will be able to provide medical professionals with a truly new paradigm in wound healing and reconstructive surgery by utilizing a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. it is because polarityte uses a natural and biologically sound platform technology, which is readily adaptable to a wide spectrum of organ and tissue systems, that the company and its world-renowned clinical advisory board, are poised to drastically change the field and future of translational regenerative medicine. more info can be found online at www.polarityte.com welcome to the shift™

PolarityTE Inc executives and stock owners

PolarityTE Inc executives and other stock owners filed with the SEC include:

• Richard Hague,
  Pres & CEO
• Cameron J. Hoyler,
  Gen. Counsel, Sec. and Exec. VP of Corp. Devel. & Strategy
• Daniel Gasiorowski,
  Investor Relations Contact Officer
• Wladyslaw Zmuda,
  Member of the Supervisory Board
• Michal Zadlo,
  Member of the Supervisory Board
• Beata Sobocinska,
  Member of the Supervisory Board
• Kamila Krawiec,
  Member of the Supervisory Board
• Michal Herominski,
  Member of the Supervisory Board
• Patryk Gall,
  Member of the Supervisory Board
• Emil Cybulski,
  Member of the Supervisory Board
• Pawel Cieslik,
  Member of the Supervisory Board
• Maria Biernacik-Bankowska,
  Member of the Supervisory Board
• Agnieszka Kosno,
  Chief Accounting Officer
• Zbigniew Stawinoga,
  Chairman of the Management Board
• Rafal Markiewicz,
  Chairman of the Supervisory Board
• Mark E. Lehman J.D.,
  Chief Legal Officer
• Ryan Mathis M.D.,
  Chief Medical Officer
• Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.,
  Sr. VP of Corp. Devel. & Pres of Contract Services
• Dr. Stephen Milner M.D., DDS, DSc, FRCSE, FACS,
  Chief Clinical Officer & Member of Clinical Advisory Board
• Alain Adam,
  VP of Sales
• Angela Ziegler,
  VP of Marketing & PR
• Rich Haerle,
  VP of Investor Relations & Strategy
• Nikolai Sopko,
  Chief Scientific Officer and VP of R&D
• Jacob Alexander Patterson,
  Chief Financial Officer
• Jacob Alexander Patterson,
  Chief Financial Officer
• Chris Nolet,
  Director
• Jessica Xiaolin Shen,
  Director
• David B Seaburg,
  Director
• Jon Mogford,
  Director
• Rainer M Erdtmann,
  Director
• Peter A Cohen,
  Director
• Paul Elliot Mann,
  Chief Financial Officer
• Edward Winslow Swanson,
  Chief Trans. Med. Officer
• Steve Gorlin,
  Director
• Jeffrey Hansen Dyer,
  Director
• Willie C. Bogan,
  Director
• Minnie Baylor Henry,
  Director
• Denver Lough,
  
• Richard Hague,
  Chf. Exec. Off. & Pres.
• Cameron J. Hoyler,
  Gen. Counsel & Exec. VP